Or explore alternative tirzepatide delivery methods that may reduce GI side effects
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under clinical investigation and not yet approved by the MHRA or EMA
Ideal For: Anyone prone to acid reflux, nausea, or stomach upset during IV therapy
This is to quickly increase vitamin B12 levels
239-333-8809 2590 Golden Gate Parkway, Suite 104 Naples FL 34105 Board Certified Physicians Dr
What you dont pay for (and may want to add): pre-treatment labs to confirm baseline IGF-1 and rule out contraindications, ongoing lab monitoring, and a longer-term clinical relationship